Nora Katabi

7PUBLICATIONS
80CO-AUTHORS
Molecular targetsAutonomic nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
A Phase 2 Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 Amplified Cancers: A Non-Randomized Clinical Trial.

|Jan 28, 2026
Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer.

Manu Prasad, Alex T Cheng, Marcel Mayer

|Apr 24, 2025
Sympathetic axonogenesis promotes adenoid cystic carcinoma progression.

Chun-Hao Chen, Boris Reva, Nora Katabi

|Dec 04, 2024
Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions.

Ying-Hsia Chu, Nora Katabi, Purvil Sukhadia

|Oct 01, 2024
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma.

Antoine Desilets, Joris L Vos, Nora Katabi

|Apr 02, 2021
Clinicopathologic Characteristics of Young Patients with Oral Squamous Cell Carcinoma.

Wadad S Mneimneh, Bin Xu, Charles Ghossein

Pageof 2

Frequent Collaborators

5 joint publications

Alan L Ho

3 joint publications

Luc G T Morris

2 joint publications

Bin Xu

2 joint publications

Richard J Wong